Omer Iqbal, MD, FACC, FESC. is a Professor of Pathology and Ophthalmology at Loyola University Medical Center in Maywood, Illinois, USA. He is an elected fellow in the American College of Cardiology and European Society of Cardiology. For nearly three decades he has been actively involved in research in the field of Hemostasis and Thrombosis. His scientific interests are wide and varied including diabetic retinopathy, keratoconus, age-related macular degeneration, Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), Precision Medicine, mechanism of carcinogenesis, cancer-associated hypercoagulation, interventional cardiology, echocardiography, air travel thrombosis, new anticoagulant drugs, anti-platelet drugs, thrombolytic drugs, personalized medicine, Clinical trials, pharmacogenomics, pharmacogenetics, microarray technology, and nanotechnology. He is currently working on the molecular pathogenesis of keratoconus, SJS/TEN, molecular mechanism of action and point-of-care monitoring of new oral and intravenous anti-thrombin, anti-Xa anticoagulant drugs, Glycoprotein IIb/IIIa receptor antagonists and thrombolytic agents. He is an inaugural ambassador of the Institute of Transformative and Interprofessional Education (ITIE). He is a member of numerous national and international scientific organizations including ISTH, IUA, ASH, AHA, ACC, ESC and ASCO. He has been an invited speaker at several national and international scientific meetings. He has authored and co-authored over 100 publications and 16 book chapters.